GT Biopharma, Inc.
GTBPNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $7.87M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.26$13.94
- Volume (live)
- -
- Avg. volume (3M)
- 67.78K
GT Biopharma (GTBP) Stock Price & Financial Analysis
GT Biopharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $5.07 - $5.78 |
|---|---|
| 52-Week High | $13.94 |
| 52-Week Low | $0.26 |
| Open | $5.49 |
| Volume (last close) | 178.77K |
| Average Volume (3M) | 67.78K |
| 50-Day MA | $7.06 |
|---|---|
| 200-Day MA | $4.15 |
| 1-Year Change | +655.13% |
| Market Cap | 7.87M |
|---|---|
| Shares Outstanding | 1.55M |
| Price to Book (P/B) | 2.21 |
| EV/EBITDA | -0.11 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
GT Biopharma at a Glance
As of the Oct 26, 2026 close, GT Biopharma (GTBP) has a market capitalization of $7.87M.
As of its latest reported balance sheet, it holds $4.96M in cash and securities against $0.00 of debt, a net cash position of $4.96M.
GT Biopharma does not currently pay a dividend.
The share price is up 655.1% over the past year. At $5.07 (the Oct 26, 2026 close) it sits within its 52-week range of $0.26 to $13.94, above its 200-day moving average of $4.15.
Frequently Asked Questions About GT Biopharma
What is the current stock price for GTBP?
As of the Oct 26, 2026 close, GTBP stock trades at $5.07. The 52-week range is $0.26–$13.94, with a day range of $5.07–$5.78.
What is the P/E ratio for GTBP?
The P/E ratio (Price-to-Earnings) for GTBP is shown in the Key Statistics section. This valuation metric helps compare GT Biopharma, Inc. to industry peers.
Does GTBP pay dividends?
GT Biopharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for GTBP?
Analyst ratings and recommendations for GTBP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of GTBP?
As of the Oct 26, 2026 close, GT Biopharma's market capitalization is $7.9M, classifying it as a micro-cap company. GT Biopharma operates in the Healthcare sector within the Biotechnology industry.